GGrantIndex
← Leaderboards

Lauren O Bakaletz

Research Inst Nationwide Children'S Hosp

$21,163,452
Attributed
$25,629,693
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,629,693 · 7

By mechanism

R01$25,498,393 · 5
R13$131,300 · 2

Most similar at Research Inst Nationwide Children'S Hosp

Same institution · by research overlap

Others in their field

Top investigators on “Otitis Media

Research focus

Otitis MediaVaccine DevelopmentPreventMiddle EarAcuteVaccinesChronicPreventionPathogenesisNontypable Haemophilus InfluenzaPathogenChildhoodMicrobial BiofilmsChildDesignImmunityMolecularBacteriaAntibioticsLifeImmuneIn VivoChinchilla (Genus)Recurrence

Grant awards (64)

Determinants of H. influenzae Virulence in Otitis Media$611,942
R01 · FY2025 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$630,017
R01 · FY2024 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$622,078
R01 · FY2023 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$618,960
R01 · FY2022 · DC · contact PI
International Symposia on Recent Advances in Otitis Media$39,900
R13 · FY2022 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$626,261
R01 · FY2021 · DC · contact PI
International Symposia on Recent Advances in Otitis Media$100
R13 · FY2021 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$574,522
R01 · FY2020 · DC · contact PI
Otitis media: role of epigenetic regulation on NTHI pathogenesis and optimal vaccine design$373,743
R01 · FY2020 · DC · contact PI
International Symposia on Recent Advances in Otitis Media$15,650
R13 · FY2020 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$591,017
R01 · FY2019 · DC · contact PI
Otitis media: role of epigenetic regulation on NTHI pathogenesis and optimal vaccine design$459,856
R01 · FY2019 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$401,563
R01 · FY2019 · DC · contact PI
International Symposia on Recent Advances in Otitis Media$100
R13 · FY2019 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$586,252
R01 · FY2018 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$460,263
R01 · FY2018 · DC · contact PI
Otitis media: role of epigenetic regulation on NTHI pathogenesis and optimal vaccine design$427,730
R01 · FY2018 · DC · contact PI
International Symposia on Recent Advances in Otitis Media$35,550
R13 · FY2018 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$577,336
R01 · FY2017 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$473,579
R01 · FY2017 · DC · contact PI
Otitis media: role of epigenetic regulation on NTHI pathogenesis and optimal vaccine design$453,853
R01 · FY2017 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$610,246
R01 · FY2016 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$456,860
R01 · FY2016 · DC · contact PI
Otitis media: role of epigenetic regulation on NTHI pathogenesis and optimal vaccine design$454,657
R01 · FY2016 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$455,547
R01 · FY2015 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$402,574
R01 · FY2015 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$477,402
R01 · FY2014 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$451,194
R01 · FY2014 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$481,705
R01 · FY2013 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$460,738
R01 · FY2013 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$563,222
R01 · FY2012 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$556,610
R01 · FY2012 · DC · contact PI
Antimicrobial Peptides and Innate Immunity in Otitis Media$397,388
R01 · FY2012 · DC · contact PI
Novel immunotherapeutics for the management of otitis media due to H. influenzae$495,349
R01 · FY2011 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$423,069
R01 · FY2011 · DC · contact PI
Antimicrobial Peptides and Innate Immunity in Otitis Media$397,388
R01 · FY2011 · DC · contact PI
10th International Post-Symposium Research Conference on Recent Advances in Otiti$40,000
R13 · FY2011 · DC · contact PI
Antimicrobial Peptides and Innate Immunity in Otitis Media$497,778
R01 · FY2010 · DC · contact PI
RSV Upper Airway Infection and Otitis Media$438,448
R01 · FY2010 · DC
Determinants of H. influenzae Virulence in Otitis Media$426,862
R01 · FY2010 · DC · contact PI
Antimicrobial Peptides and Innate Immunity in Otitis Media$557,240
R01 · FY2009 · DC · contact PI
RSV Upper Airway Infection and Otitis Media$450,553
R01 · FY2009 · DC
Determinants of H. influenzae Virulence in Otitis Media$232,184
R01 · FY2009 · DC · contact PI
Antimicrobial Peptides and Innate Immunity in Otitis Media$72,879
R01 · FY2009 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$470,818
R01 · FY2008 · DC · contact PI
RSV Upper Airway Infection and Otitis Media$428,678
R01 · FY2008 · DC
Antimicrobial Peptides and Innate Immunity in Otitis Media$428,553
R01 · FY2008 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$461,408
R01 · FY2007 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$455,326
R01 · FY2006 · DC · contact PI
Antimicrobial Peptides & Innate Immunity in Otitis Media$352,096
R01 · FY2006 · DC · contact PI
Determinants of H. influenzae Virulence in Otitis Media$453,917
R01 · FY2005 · DC
Antimicrobial Peptides &Innate Immunity in Otitis Media$378,480
R01 · FY2005 · DC
Determinants of H. influenzae Virulence in Otitis Media$466,548
R01 · FY2004 · DC
Antimicrobial Peptides &Innate Immunity in Otitis Media$364,584
R01 · FY2004 · DC
DETERMINANTS OF H. INFLUENZAE VIRULENCE IN OTITIS MEDIA$484,850
R01 · FY2003 · DC
Antimicrobial Peptides &Innate Immunity in Otitis Media$368,332
R01 · FY2003 · DC
DETERMINANTS OF H. INFLUENZAE VIRULENCE IN OTITIS MEDIA$553,641
R01 · FY2002 · DC
Antimicrobial Peptides &Innate Immunity in Otitis Media$343,877
R01 · FY2002 · DC
DETERMINANTS OF H. INFLUENZAE VIRULENCE IN OTITIS MEDIA$471,312
R01 · FY2001 · DC
DETERMINANTS OF H INFLUENZAE VIRULENCE IN OTITIS MEDIA$120,306
R01 · FY2001 · DC
DETERMINANTS OF H. INFLUENZAE VIRULENCE IN OTITIS MEDIA$66,781
R01 · FY2001 · DC
DETERMINANTS OF H. INFLUENZAE VIRULENCE IN OTITIS MEDIA$474,025
R01 · FY2000 · DC
DETERMINANTS OF H. INFLUENZAE VIRULENCE IN OTITIS MEDIA$55,996
R01 · FY2000 · DC
DETERMINANTS OF H. INFLUENZAE VIRULENCE IN OTITIS MEDIA$50,000
R01 · FY2000 · DC